摘要
为了控制抗癌药甲苯磺酸索拉非尼产品质量,制备了可能的5种有关物质,4-(4-氨基甲酸乙酯苯氧基)-N-甲基-2-吡啶甲酰胺(A),4-氯-3-(三氟甲基)苯胺(B),4-氯-3-三氟甲基苯基氨基甲酸乙酯(C),1,3-二(4-氯-3-(三氟甲基)苯基)脲(D),4-(4-{3-[3-(三氟甲基)苯基]脲基}苯氧基)-N2-甲基吡啶-2-羧酰胺(E),并经1H-NMR,13CNMR,ESI-MS等确证结构。
To perform the quality control of anticarcinogen drug sorafenib tosylate,five related substanceswere prepared,and their structures were confirmed by1H- NMR,13C- NMR and ESI- MS. These substances were ethyl( 4-(( 2-( methyl- carbamoyl) pyridin- 4- yl) oxy) phenyl) carbamate( A),4- chloro- 3-( trifluoromethyl) aniline( B),ethyl( 4- chloro- 3-( trifluoromethyl) phenyl) carbamate( C),1,3- bis( 4- chloro- 3-( trifluoromethyl) phenyl) urea( D),4-( 4-( 3-( 3-( trifluoromethyl) phenyl) ureido) phenoxy)- N- methyl picolinamide( E).
出处
《山东化工》
CAS
2016年第2期37-39,42,共4页
Shandong Chemical Industry
关键词
抗癌药
甲苯磺酸索拉非尼
有关物质
合成
anticarcinogen drug
sorafenib tosylate
related substance
synthesis